34 results on '"Hudes G"'
Search Results
2. UNRECOGNIZED PARASITIC INFECTION AS A CAUSE OF PERSISTENT EOSINOPHILIA IN AN INNER-CITY ALLERGY CLINIC POPULATION
3. Dichlorophenol-containing pesticides and allergies: results from the US National Health and Nutrition Examination Survey 2005-2006.
4. Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma.
5. Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
6. Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents.
7. A case of common variable immunodeficiency syndrome associated with Takayasu arteritis.
8. M411 ACTIVE TUBERCULOSIS (TB) MASQUERADING AS AN ASTHMA EXACERBATION DURING A SARS-COV-2 (COVID 19) PANDEMIC.
9. M405 COVID-19 ASSOCIATED EOSINOPHILIC LICHEN PLANUS.
10. M304 SOY MILK ANAPHYLAXIS IN PATIENTS WITH NEGATIVE SOY SPECIFIC IGE AND SKIN TEST: DIAGNOSTIC CHALLENGE.
11. P226 EFFECT OF OMALIZUMAB IN ASTHMA PATIENTS BY NUMBER OF ASTHMA-RELATED AND ALLERGIC COMORBIDITIES IN PROSPERO.
12. Phase I trial of 5-fluorouracil by 24-hour infusion weekly
13. Prostate Specific Antigen Density is not an Independent Predictor of Response for Prostate Cancer Treated by Conformal Radiotherapy
14. M411 ACTIVE TUBERCULOSIS (TB) MASQUERADING AS AN ASTHMA EXACERBATION DURING A SARS-COV-2 (COVID 19) PANDEMIC
15. M405 COVID-19 ASSOCIATED EOSINOPHILIC LICHEN PLANUS
16. DELAYED URTICARIA AND ANGIOEDEMA FOLLOWING YELLOW FEVER VACCINE IMMUNIZATION
17. P049 Acute interstitial pneumonitis following talc-pleurodesis.
18. P345 Systemic contact dermatitis resulting from patch testing to vanadium.
19. Chronic urticaria with monoclonal IgG gammopathy: a clinical variant of Schnitzler syndrome?
20. 7113 Radiographic findings of drug-induced pneumonitis and clinical correlation in patients with advanced renal cell carcinoma treated with temsirolimus.
21. 4011 POSTER Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-a or the combination of temsirolimus + interferon-a.
22. Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients With Advanced Renal Cell Carcinoma.
23. P345 Systemic contact dermatitis resulting from patch testing to vanadium
24. P049 Acute interstitial pneumonitis following talc-pleurodesis
25. The Urticaria Severity Score May Serve As An Early Clinical Indicator In Monitoring Patients With Chronic Urticaria.
26. 7134 Evaluation of quality of life in patients with advanced renal cell carcinoma treated with temsirolimus vs interferon-alfa: results from a phase III randomized trial.
27. 7108 Phase II study of IMC-1121B in patients with metastatic renal cell carcinoma (mRCC) following failure of VEGFR-2 tyrosine kinase inhibitor (TKI) therapy: interim results (IMCL CP12–0605/NCT00515697).
28. FEVER, RASH AND WORSENING OF ASTHMA IN RESPONSE TO INTRAVENOUS HYDROCORTISONE
29. Allergen Immunotherapy in Three Patients with Human Immunodeficiency Virus.
30. 4520 POSTER Sunitinib plus interferon-alfa in the first-line treatment for metastatic renal cell carcinoma (mRCC): results of a dose-finding study.
31. 4507 ORAL Axitinib (AG-013736; AG) in patients (pts) with metastatic clear cell renal cell cancer (RCC) refractory to sorafenib.
32. A Novel Case of Gaucher's Disease Associated with Hypogammaglobulinemia.
33. 343 POSTER Phase I dose escalation study of the aurora kinase inhibitor PHA-739358 administered as a 24 hours infusion in a 14-day cycle in patients with advanced/metastatic solid tumor.
34. Preclinical and clinical perspectives on the use of estramustine as an antimitotic drug
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.